ACOG NASDAQ
Alpha Cognition Inc. Common Stock
1W: +5.7%
1M: -15.8%
3M: +0.0%
YTD: +17.9%
1Y: +39.1%
$5.80
+0.05 (+0.87%)
Weekly Expected Move ±9.3%
$5
$5
$6
$7
$7
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider+$2.4M
Congress—
ETF Holdings—
Key Statistics
Market Cap$90.1M
52W Range4.5-11.54
Volume15,637
Avg Volume58,583
Beta2.39
Dividend—
Analyst Ratings
Company Info
CEOMichael E. McFadden
Employees5
SectorFinancial Services
IndustryFinancial - Conglomerates
IPO Date2024-11-12
Websitealphacognition.com
750 West Pender Street
Vancouver, BC V6C 2T8
CA
Vancouver, BC V6C 2T8
CA
858 344 4375
About Alpha Cognition Inc. Common Stock
Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company offers ZUNVEYL (benzgalantamine) for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury. It also develops ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.
Latest News
Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Tops Revenue Estimates
Alpha Cognition (ACOG) Q1 2026 Earnings Transcript
12 Health Care Stocks Moving In Thursday's After-Market Session
Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Alpha Cognition Inc. (ACOG) Soars 8.6%: Is Further Upside Left in the Stock?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| D'Angelo Lauren | P-Purchase | 3,500 | $5.76 | 2026-05-19 |
| Opaleye Management I | P-Purchase | 17,395 | $5.69 | 2026-05-18 |
| Opaleye Management I | P-Purchase | 16,648 | $5.83 | 2026-05-15 |
| Sensenig Bethany | A-Award | 6,991 | $6.65 | 2026-04-16 |
| Sensenig Bethany | A-Award | 5,489 | — | 2026-04-16 |